ESSA Pharma Inc. — Director's Dealing 2022

Jul 5, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ESSA Pharma Inc. (EPIX)
CIK: 0001633932
Period of Report: 2022-06-30

Reporting Person: Parkinson David Ross (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-06-30	Common Shares	P	4887	$2.958	Acquired	32108	Direct

Footnotes

F1: Shares purchased through the Issuer's Employee Share Purchase Plan.